Demyelinizing Neurological Disease after Treatment with Tumor Necrosis Factor-α Antagonists

Purpose: Demyelinizing neurological disease is a rare complication after treatment with tumor necrosis factor (TNF)α antagonists. We report on a case of multiple sclerosis after TNFα antagonist treatment and discuss its differential diagnosis. Methods: This is an observational case study. Results: A...

Full description

Bibliographic Details
Main Authors: Claudia Bruè, Cesare Mariotti, Ilaria Rossiello, Andrea Saitta, Alfonso Giovannini
Format: Article
Language:English
Published: Karger Publishers 2016-07-01
Series:Case Reports in Ophthalmology
Subjects:
Online Access:http://www.karger.com/Article/FullText/447086